Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
NCT05853198
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
165
Enrollment
OTHER
Sponsor class
Conditions
PDAC - Pancreatic Ductal Adenocarcinoma
Interventions
OTHER:
ctDNA analysis
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona